Data / Drug companies / Dutasteride
Dutasteride: 14 companies and 22 products in the FDA NDC directory
Dutasteride is listed in the FDA National Drug Code Directory by 14 companies, with 22 products in commercial distribution. 22 of the products (100.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are capsule, liquid filled; capsule, and the newest product started marketing on October 26, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 14
- Products
- 22
- Generic (ANDA) products
- 22 (100.0%)
- Application numbers
- 7
- Routes
- Oral
- openFDA record search
- api.fda.gov
Companies that list dutasteride
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| NuCare Pharmaceuticals,Inc. | 4 | capsule, liquid filled | Generic drugs (ANDA) | November 28, 2017 |
| A-S Medication Solutions | 3 | capsule, liquid filled | Generic drugs (ANDA) | January 20, 2023 |
| Bryant Ranch Prepack | 3 | capsule, liquid filled | Generic drugs (ANDA) | October 24, 2016 |
| Proficient Rx LP | 2 | capsule, liquid filled; capsule | Generic drugs (ANDA) | October 24, 2016 |
| Amneal Pharmaceuticals LLC | 1 | capsule | Generic drugs (ANDA) | November 2, 2015 |
| Aurobindo Pharma Limited | 1 | capsule, liquid filled | Generic drugs (ANDA) | January 20, 2023 |
| AvKARE | 1 | capsule | Generic drugs (ANDA) | October 26, 2026 |
| Banyan Pharma LLC | 1 | capsule | Generic drugs (ANDA) | December 31, 2025 |
| Bryant Ranch Prepack | 1 | capsule, liquid filled | Generic drugs (ANDA) | October 24, 2016 |
| Camber Pharmaceuticals, Inc. | 1 | capsule, liquid filled | Generic drugs (ANDA) | October 24, 2016 |
| Epic Pharma, LLC | 1 | capsule, liquid filled | Generic drugs (ANDA) | November 28, 2017 |
| Marksans Pharma Limited | 1 | capsule, liquid filled | Generic drugs (ANDA) | April 27, 2017 |
| Strides Pharma Science Limited | 1 | capsule, liquid filled | Generic drugs (ANDA) | December 9, 2016 |
| XLCare Pharmaceuticals, Inc. | 1 | capsule, liquid filled | Generic drugs (ANDA) | March 9, 2020 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Capsule, liquid filled | 18 | 81.8% |
| Capsule | 4 | 18.2% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 22 | 100% |
Pharmacologic classes
| Class | Products |
|---|---|
| 5-alpha Reductase Inhibitor | 22 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.